儿童弥漫内生型脑桥胶质瘤的表观遗传重编程与染色质可及性:一种神经发育性疾病
本文综述儿童弥漫内生型脑桥胶质瘤(DIPG)的发育与表观遗传机制。DIPG最常见突变为H3F3A和HIST1H3B/C基因上的K27M突变,该突变破坏多梳抑制复合物2对组蛋白H3第27位赖氨酸的甲基化,导致整体低甲基化。组蛋白H3第27位赖氨酸三甲基化是控制基因表达的重要发育调控因子,DIPG的表观遗传编程具有深刻治疗意义。
要点
- DIPG最常见突变为H3F3A和HIST1H3B/C基因上的K27M突变。
- K27M突变破坏多梳抑制复合物2对组蛋白H3第27位赖氨酸的甲基化,导致整体低甲基化。
- 组蛋白H3第27位赖氨酸三甲基化是控制基因表达的重要发育调控因子。
核心结论
- DIPG具有发育起源,其表观遗传编程具有深刻治疗意义。
研究设计与样本
- 综述,讨论驱动DIPG疾病进展的发育与表观遗传机制。
主要发现
- DIPG的转录组谱与其他发生于大脑半球的小儿高级别胶质瘤不同。
- DIPG最常见的突变是发生于H3F3A和HIST1H3B/C基因上的赖氨酸至甲硫氨酸(K27M)突变。
- K27M突变破坏多梳抑制复合物2对组蛋白H3第27位赖氨酸的甲基化,导致整体低甲基化。
- 组蛋白H3第27位赖氨酸三甲基化是控制基因表达的重要发育调控因子。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Diffuse intrinsic pontine glioma (DIPG) is a rare but deadly pediatric brainstem tumor. To date, there is no effective therapy for DIPG. Transcriptomic analyses have revealed DIPGs have a distinct profile from other pediatric high-grade gliomas occurring in the cerebral hemispheres. These unique genomic characteristics coupled with the younger median age group suggest that DIPG has a developmental origin. The most frequent mutation in DIPG is a lysine to methionine (K27M) mutation that occurs on H3F3A and HIST1H3B/C, genes encoding histone variants. The K27M mutation disrupts methylation by polycomb repressive complex 2 on histone H3 at lysine 27, leading to global hypomethylation. Histone 3 lysine 27 trimethylation is an important developmental regulator controlling gene expression. This review discusses the developmental and epigenetic mechanisms driving disease progression in DIPG, as well as the profound therapeutic implications of epigenetic programming.
引用
- Mendez FM, Núñez FJ, Garcia-Fabiani MB, et al. Epigenetic reprogramming and chromatin accessibility in pediatric diffuse intrinsic pontine gliomas: a neural developmental disease. Neuro Oncol. 2020. PMID: 32078691. doi:10.1093/neuonc/noz218
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。